Anti-interleukin-5 therapy and severe asthma.
Zarogiannis
Sotirios
S
Gourgoulianis
Konstantinos I
KI
Kostikas
Konstantinos
K
D000397:Air Pollution / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D004802:Eosinophilia / Q000188:drug therapy*; D006801:Humans; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D012008:Recurrence
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5; C434107:mepolizumab